Before starting my GLP-1 journey, I spent weeks researching the differences between semaglutide and tirzepatide. I thought I’d share what I learned in case it helps others who are trying to decide between the two.
Disclaimer: I’m not a medical professional – this is just information I gathered from research papers, forums, and conversations with my healthcare provider. Always consult your doctor for medical advice.
The Basics
Semaglutide (brand names: Ozempic, Wegovy, Rybelsus)
- GLP-1 receptor agonist
- FDA approved for diabetes (2017) and weight management (2021)
- Available as weekly injection or daily oral tablet
Tirzepatide (brand names: Mounjaro, Zepbound)
- Dual GIP/GLP-1 receptor agonist (works on TWO receptors)
- FDA approved for diabetes (2022) and weight management (2023)
- Available as weekly injection only
Key Differences I Found
1. Mechanism of Action
The biggest difference is that tirzepatide targets both GIP and GLP-1 receptors, while semaglutide only targets GLP-1. The dual action is thought to provide additional benefits for glucose control and potentially weight loss.
2. Weight Loss Results (from clinical trials)
- Semaglutide: Average of 15-17% body weight loss in the STEP trials
- Tirzepatide: Average of 20-22% body weight loss in the SURMOUNT trials
Keep in mind these are averages from clinical trials – individual results vary significantly.
3. Dosing
- Semaglutide: Starts at 0.25mg, titrates up to 2.4mg (for weight management)
- Tirzepatide: Starts at 2.5mg, titrates up to 15mg
4. Side Effects
Both medications share similar GI side effects (nausea, vomiting, diarrhea, constipation). From what I’ve read in forums and studies:
- Some people tolerate one better than the other
- Side effects often improve after the first few weeks
- Slower titration can help minimize side effects
5. Cost & Availability
This is where things get complicated:
- Brand-name versions of both are expensive without insurance
- Insurance coverage varies widely
- Compounded versions exist but quality varies
- Shortages have affected both medications at various times
What Influenced My Decision
I ultimately went with semaglutide because:
- It’s been on the market longer (more long-term safety data)
- My insurance covered it better
- My doctor had more experience prescribing it
That said, I know plenty of people who’ve had great results with tirzepatide, especially those who didn’t respond as well to semaglutide.
Questions for Discussion
- For those who’ve tried both – did you notice significant differences?
- What factors influenced your choice between the two?
- Anyone switch from one to the other? What was your experience?
I’m genuinely curious about real-world experiences beyond the clinical trial data. Would love to hear your thoughts!